Dr Michael Joseph Aronica, MD | |
1609 Jefferson Ave, Dunmore, PA 18509 | |
(570) 347-1186 | |
Not Available |
Full Name | Dr Michael Joseph Aronica |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 1609 Jefferson Ave, Dunmore, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700345279 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | PA026540L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael Joseph Aronica, MD 1609 Jefferson Ave, Dunmore, PA 18509 Ph: (570) 347-1186 | Dr Michael Joseph Aronica, MD 1609 Jefferson Ave, Dunmore, PA 18509 Ph: (570) 347-1186 |
News Archive
Proteins within the bacteria that cause Legionnaire's disease can kidnap their own molecular "coffin" and carry it to a safe place within the cell, ensuring their survival, Yale School of Medicine researchers report in Nature Wednesday.
A new study uncovers which cell types can be infected by SARS-CoV-2 due to their viral entry factors. The study also suggests that increased gene expression of these viral entry factors in some individuals partially explains the differences of COVID-19 severity reported in relation to age, gender and smoking status.
Mayo Clinic Health System Practice-Based Research Network (PBRN) is sharing in an $11 million government grant to lead the creation of a national learning collaborative among rural health care providers. The effort is part of a national partnership using the Health Care Innovation Award funded by the Affordable Care Act.
Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.
High-density lipoprotein cholesterol could provide a novel treatment target for patients with lymphoma, US scientists believe.
› Verified 8 days ago